- Home
- SDHY vs HRTX Comparison
SDHY vs HRTX Comparison
Compare SDHY & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDHY
- HRTX
- Stock Information
- Founded
- SDHY 2020
- HRTX 1983
- Country
- SDHY United States
- HRTX United States
- Employees
- SDHY N/A
- HRTX N/A
- Industry
- SDHY Finance/Investors Services
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- SDHY Finance
- HRTX Health Care
- Exchange
- SDHY Nasdaq
- HRTX Nasdaq
- Market Cap
- SDHY 400.4M
- HRTX 325.0M
- IPO Year
- SDHY N/A
- HRTX 1987
- Fundamental
- Price
- SDHY $16.48
- HRTX $1.98
- Analyst Decision
- SDHY
- HRTX Strong Buy
- Analyst Count
- SDHY 0
- HRTX 2
- Target Price
- SDHY N/A
- HRTX $5.00
- AVG Volume (30 Days)
- SDHY 94.0K
- HRTX 1.1M
- Earning Date
- SDHY 01-01-0001
- HRTX 08-05-2025
- Dividend Yield
- SDHY 8.46%
- HRTX N/A
- EPS Growth
- SDHY N/A
- HRTX N/A
- EPS
- SDHY 1.07
- HRTX N/A
- Revenue
- SDHY N/A
- HRTX $148,518,000.00
- Revenue This Year
- SDHY N/A
- HRTX $12.08
- Revenue Next Year
- SDHY N/A
- HRTX $12.57
- P/E Ratio
- SDHY $14.31
- HRTX N/A
- Revenue Growth
- SDHY N/A
- HRTX 12.43
- 52 Week Low
- SDHY $13.93
- HRTX $1.04
- 52 Week High
- SDHY $15.50
- HRTX $3.73
- Technical
- Relative Strength Index (RSI)
- SDHY 61.59
- HRTX 49.25
- Support Level
- SDHY $16.22
- HRTX $1.90
- Resistance Level
- SDHY $16.53
- HRTX $2.07
- Average True Range (ATR)
- SDHY 0.11
- HRTX 0.10
- MACD
- SDHY 0.01
- HRTX 0.00
- Stochastic Oscillator
- SDHY 75.55
- HRTX 32.81
About SDHY PGIM Short Duration High Yield Opportunities Fund
PGIM Short Duration High Yield Opportunities is a closed-end management investment company. The fund's investment objective is to provide total return, through a combination of current income and capital appreciation. Its seeks to achieve its objective by investing in a diversified portfolio of high yield fixed income instruments.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.